MYC and Burkitt lymphoma: In this regard, Hartleben et al.189 observed that MYC-driven upregulation of tuberous sclerosis complex 1 (TSC1) in Burkitt’s lymphoma cells represses the activation of mTORC1, thus limiting the production of ROS by the ETC.